Sarepta Therapeutics Inc. (SRPT)

AI Score

Unlock

62.33

0.42 (0.68%)

At close: Apr 02, 2025, 3:59 PM

57.50

-7.75%

After-hours: Apr 02, 2025, 05:31 PM EDT

Dividends

No dividend history available for Sarepta Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

SRPT News

Just now · Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sarepta Therapeutics, Inc. (SRPT) And Encourages Shareholders to Reach Out - accessnewswire.com
Just now · INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT - accessnewswire.com
23 hours ago · Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sarepta Therapeutics, Inc. (SRPT) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
1 day ago · Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr. - zacks.com
2 days ago · Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - businesswire.com
2 days ago · Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul - nypost.com
1 day ago · Sarepta Therapeutics, Inc. (SRPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - accessnewswire.com
2 days ago · Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sarepta Therapeutics, Inc. (SRPT) and Encourages Investors to Learn More About the Investigation - accessnewswire.com
5 days ago · Sarepta Therapeutics, Inc. (SRPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
1 week ago · Bronstein, Gewirtz & Grossman, LLC Encourages Sarepta Therapeutics, Inc. (SRPT) Stockholders to Inquire about Securities Investigation - accessnewswire.com